Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.

AIDS (London, England) - 28 Nov 2012

I Lorenzini Kuntheavy, Calmy Alexandra, Ambrosioni Juan, Assouline Benjamin, Daali Youssef, Fathi Marc, Rebsamen Michela, Desmeules Jules, Samer Caroline F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Citalopram
Share to Coinfection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Darunavir

Share to Drug Interactions

Share to HIV Protease Inhibitors

Share to Ritonavir

Source

Identifiers

PMID: 23151497
DOI: 10.1097/QAD.0b013e32835a11ba

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.PMID 23151497Read ↗

Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression.Semantic proximity Read ↗

Drug interactions--friend or foe?Semantic proximity Read ↗

Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patientsSemantic proximity Read ↗

Polymorphisms in the 5-Hydroxytryptamine 2A Receptor and CytochromeP4502D6 Genes Synergistically Predict Fluvoxamine-Induced Side Effects in Japanese Depressed PatientsSemantic proximity Read ↗

Pharmacokinetic drug-drug interaction study between raltegravir and citalopram.Semantic proximity Read ↗

eComment: Serotonin syndrome: pharmacogenomics and treatment.Semantic proximity Read ↗

Pharmacogenetic workup of perioperative serotonin syndrome.Semantic proximity Read ↗

CYP2B6 516 G>T polymorphism and side effects of the central nervous system in HIV-positive individuals under Efavirenz treatment: Study of a sample from southern Brazil.Semantic proximity Read ↗

Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine.Semantic proximity Read ↗

Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report.Semantic proximity Read ↗

Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetineSemantic proximity Read ↗

Correlation of CYP2B6-516G > T Polymorphism with Plasma Efavirenz Concentration and Depression in HIV-Infected Adults in Northern Thailand.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.